Tag: UTRF


News

Collaborative Research Leads to Creative Solution

|

Can a candy be good for your teeth? It can be, with the right ingredients. Researchers from the College of Dentistry and the College of Pharmacy at the University of Tennessee Health Science Center have worked together to develop lollipop that is changing the way erosion of tooth enamel is treated. Searching for Options The… Read More


News

Scientists at UTHSC and ORNL Collaborate to Develop Potential New Treatment for Advanced Prostate Cancer

|

Nearly five years after beginning their research, investigators from the University of Tennessee Health Science Center, with collaboration from scientists at Oak Ridge National Laboratory (ORNL), have found what they believe will be a next generation treatment option for advanced prostate cancer. Clinical Cancer Research, a high-impact journal in the cancer field, published a paper on… Read More


News

GTx and the University of Tennessee Research Foundation Enter Into Exclusive License Agreement to Develop SARD Drug Candidate to Treat Castration-Resistant Prostate Cancer

|

GTx, Inc. today announced that it has entered into an exclusive worldwide license agreement with the University of Tennessee Research Foundation (UTRF) to develop its proprietary selective androgen receptor degrader (SARD) technology which potentially can degrade and inhibit all forms of androgen receptor (AR), including those resistant to current therapies, to inhibit tumor growth in… Read More